CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
2.210
-0.065 (-2.87%)
Apr 2, 2026, 12:10 PM EDT - Market open
CNSP's stock price has decreased by -86.06% in the past year and price targets may not have had time to catch up.
CNS Pharmaceuticals Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$20.00
Upside
+804.98%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $20 | Hold → Strong Buy | Upgrades | $20 | +804.98% | Sep 12, 2025 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 25, 2025 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $300 | Hold → Strong Buy | Upgrades | $300 | +13,474.66% | Sep 10, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $9,000,000 | Strong Buy | Initiates | $9,000,000 | +407,239,719.00% | Feb 2, 2021 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $9,900,000 | Strong Buy | Initiates | $9,900,000 | +447,963,700.90% | Aug 24, 2020 |